Cyanotic congenital heart disease and coronary artery atherogenesis

Alistair Fyfe1, Joseph K Perloff, Koichiro Niwa

  • 1Dallas Heart Group, Dallas, TX, USA.

Insights

Adults with cyanotic congenital heart disease (CCHD) exhibit antiatherogenic changes, including low cholesterol and unobstructed coronary arteries. These findings suggest a genetic link to hypocholesterolemia, protecting against atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Lipid Metabolism

Background:

  • High-altitude residents with hypoxemia and erythrocytosis show reduced coronary atherosclerosis and low cholesterol.
  • Cyanotic congenital heart disease (CCHD) presents a similar physiological state, but its impact on coronary atherosclerosis is unestablished.

Purpose of the Study:

  • To investigate the incidence of coronary atherosclerosis in adults with CCHD.
  • To identify potential antiatherogenic mechanisms in CCHD patients, including hypocholesterolemia.

Main Methods:

  • 279 patients with CCHD were categorized into four groups based on cyanosis status and surgical intervention.
  • Coronary arteries were assessed via angiography in 59 patients and necropsy in 5 subjects.
  • Serum total cholesterol levels were measured and compared across groups.

Main Results:

  • 58% of cyanotic, non-operated patients (Group A) and 52% of operated, now acyanotic patients (Group B) had low cholesterol (<160 mg/dl), significantly lower than acyanotic controls (Groups C & D, p <0.000001).
  • Angiography revealed dilated, unobstructed coronary arteries.
  • Necropsy showed ectatic coronary arteries with medial structural abnormalities, but no atherosclerosis.

Conclusions:

  • Adults with CCHD exhibit significant antiatherogenic changes, characterized by atheroma-free coronary arteries and hypocholesterolemia.
  • Hypocholesterolemia, combined with upregulated nitric oxide, hyperbilirubinemia, hypoxemia, and low platelet counts, likely prevents atherosclerosis in CCHD.
  • Persistent hypocholesterolemia after corrective surgery suggests a potential genetic basis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...